0001225208-17-000782.txt : 20170105
0001225208-17-000782.hdr.sgml : 20170105
20170105175025
ACCESSION NUMBER: 0001225208-17-000782
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170103
FILED AS OF DATE: 20170105
DATE AS OF CHANGE: 20170105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACMILLAN STEPHEN P
CENTRAL INDEX KEY: 0001239351
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 17512106
MAIL ADDRESS:
STREET 1: 250 CAMPUS DRIVE
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
4
1
doc4.xml
X0306
4
2017-01-03
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001239351
MACMILLAN STEPHEN P
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
Deferred Stock Units
2017-01-03
4
A
0
771.0000
0.0000
A
Common Stock
771.0000
16217.0000
D
Stock Option (Right to Buy)
21.8800
2017-01-03
4
A
0
814.0000
0.0000
A
2027-01-03
Common Stock
814.0000
814.0000
D
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Reflects a value of $16,875 divided by the closing price of common stock on the date of grant.
Deferred stock units were granted in lieu of 75% of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
Reporting person received 25% of the cash compensation for the fourth quarter of 2016 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the 2017 annual meeting of stockholders.
/s/ Vance R. Brown, Attorney-in-fact
2017-01-05